Changes in Maternal Serum Thioredoxin (TRX) Levels after Delivery in Preeclamptic and Normotensive Pregnant Women

REFERENCES

• Hauth JC, Ewell MG, Levine RJ, Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000; 95:24–28.
   PubMed Web of Science ®Google Scholar
• Walker JJ. Pre-eclampsia. Lancet 2000; 356:1260–1265.
   PubMed Web of Science ®Google Scholar
• Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD, eds. Hypertensive disorders in pregnancy. In: Williams Obstetrics. 21st ed., New York: McGraw-Hill, 2001:567–618.
   Google Scholar
• Morris JM, Gopaul NK, Endresen MJ, Circulating markers of oxidative stress are raised in normal pregnancy and preeclampsia. Br J Obstet Gynecol 1998; 105:1195–1199.
   PubMedGoogle Scholar
• Wang YP, Walsh SW, Guo J, Zhang JY. Maternal levels of prostacyclin, thromboxane, vitamin E and lipid peroxides, throughout normal pregnancy. Am J Obstet Gynecol 1991; 165:1690–1694.
   PubMed Web of Science ®Google Scholar
• Wisdom SJ, Wilson R, McKillop JH, Walker JJ. Antioxidant systems in normal pregnancy and in pregnancy induced hypertension. Am J Obstet Gynecol 1991; 165:1701–1704.
   PubMed Web of Science ®Google Scholar
• Davidge ST, Hubel CA, Brayden RD, Capeless EC, McLaughlin MK. Sera autoxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 1992; 79:897–901.
   PubMed Web of Science ®Google Scholar
• Yoshitake S, Nanri H, Fernando MR, Minakami S. Possible differences in the regenerative roles played by thioltransferase and thioredoxin for oxidatively damaged proteins. J Biochem 1994; 116:42–46.
   PubMed Web of Science ®Google Scholar
• Björnstedt M, Xue J, Huang W, Akesson B, Holmgren A. The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem 1994; 269:29382–29384.
   PubMed Web of Science ®Google Scholar
• Rozell B, Hansson HA, Luthman M, Holmgren A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol 1985; 38:79–86.
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003; 162:115–125.
   PubMed Web of Science ®Google Scholar
• Clarke FM, Orozco C, Perkins AV, Identification of molecules involved in the early pregnancy factors phenomenon. J Reprod Fert 1991; 93:525–539.
   PubMedGoogle Scholar
• Takagi Y, Nikaido T, Toki T, Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 2004; 444:49–55.
   PubMed Web of Science ®Google Scholar
• Sahlin L, Ostlund E, Wang H, Holmgren A, Fried G. Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with preeclampsia and intrauterine growth restriction. Placenta 2000; 21:603–609.
   PubMed Web of Science ®Google Scholar
• Shibata E, Ejima K, Nanri H, Enhanced protein levels of protein thiol/disulphide oxidoreductases in placentae from pre-eclamptic subjects. Placenta 2001; 22:566–572.
   PubMed Web of Science ®Google Scholar
• Vanderlelie J, Venardos K, Clifton VL, Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 2005; 26:53–58.
   PubMed Web of Science ®Google Scholar
• Report of the National High Blood Pressure Education Program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183:S1–S22.
   PubMed Web of Science ®Google Scholar
• Borzychowski AM, Sargent IL, Redman CW. Inflammation and preeclampsia. Semin Fetal Neonatal Med 2006; 11:309–316.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 2003; 24(Suppl. A):S21–S27.
   PubMed Web of Science ®Google Scholar
• Gilbert JS, Nijland MJ, Knoblich P. Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: Making the connections. Expert Rev Cardiovasc Ther 2008; 6:1367–1377.
   PubMedGoogle Scholar
• Sikkema JM, Van Rijn BB, Franx A, Placental superoxide is increased in pre-eclampsia. Placenta 2001; 22:304–308.
   PubMed Web of Science ®Google Scholar
• Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222:222–235.
   PubMed Web of Science ®Google Scholar
• George J, Struthers A. The role of urate and xanthine oxidase in vascular oxidative stress: Future directions. Ther Clin Risk Manag 2009; 5:799–803.
   PubMedGoogle Scholar
• Armitage ME, Wingler K, Schmidt HH, La M. Translating the oxidative stress hypothesis into the clinic: NOX versus NOS. J Mod Med 2009; 87:1071–1076.
   Google Scholar
• Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: An indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 2004; 286:H1389–H1393.
   PubMed Web of Science ®Google Scholar
• Manten GT, Sikkema MJ, Voorbij HA, Visser GH, Bruinse HW, Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by pre-eclampsia or intrauterine growth restriction. Hypertens pregnancy 2007; 26:39–50.
   PubMed Web of Science ®Google Scholar
• Hubel CA, Powers RW, Snaedal S, C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension 2008; 51:1499–1505.
   PubMed Web of Science ®Google Scholar
• Craici I, Wagner S, Garovic VD. Preeclampsia and future cardiovascular risk: Formal risk factor or failed stress test? Ther Adv Cardiovasc Dis 2008; 2:249–259.
   PubMedGoogle Scholar